Buck Institute | GenomeWeb

Buck Institute

The patent is based on the work of Aelan's founder and covers an epigenetic  biomarker associated with DNA damage, cellular senescence, and aging.

A team led by Buck Institute for Research on Aging scientists has reported that ApoE4 binds the promoter regions of Alzheimer's disease genes, including SirT1.

The partners will co-develop mass spectrometry-based tests to predict patient response to therapies such as tamoxifen.

A recent protein interaction study revealed that invertebrates have more in common with humans when it comes to the aging process than had been previously known, and that "the broad patterns underlying genetic control of life span in invertebrates is highly relevant to human aging and longevity."

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.